{
    "0": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Must live in the United States: The patient note doesn't mention the patient's address, but it doesn't explicitly state that they don't live in the United States either. So, I'll give this a neutral assessment.\n\n2. Must understand and write English: The patient note is written in English, and there's no indication that the patient doesn't understand or write English. So, I'll give this a neutral assessment.\n\n3. Must have access to a computer with e-mail and expect to have this access for at least 3 years: The patient note doesn't mention the patient's access to a computer or email. However, the patient is presenting to the ER, which suggests that they may have access to a computer or phone to communicate with healthcare providers. I'll give this a 1) Would consider referring this patient to this clinical trial upon further investigation.\n\n4. Must be 18 years old: The patient is 58 years old, which is above the age requirement. So, I'll give this a 0) Would not refer this patient for this clinical trial.\n\n5. Must have seen a doctor for back pain at least once in the past year: The patient note doesn't mention the patient's previous medical history or visits to doctors. However, the patient is presenting to the ER with chest pain, which is not related to back pain. So, I'll give this a 0) Would not refer this patient for this clinical trial.\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.<|eot_id|>",
        "label": 0
    },
    "1": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Age: The patient is 58 years old, which falls within the age range of 30 to 69 specified in the inclusion criteria.\n2. Gender: The patient is a woman, which is also included in the inclusion criteria.\n3. Documented myocardial infarction: The patient presents with episodic pressing/burning anterior chest pain, which is consistent with a myocardial infarction. However, the patient note does not explicitly state that the patient has a documented myocardial infarction. This is a crucial criterion for the trial.\n\nGiven that the patient note does not mention a documented myocardial infarction, I would assess the patient's eligibility as follows:\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.<|eot_id|>",
        "label": 1
    },
    "2": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Age: The patient is 58 years old, which is outside the age range of 25 to 49 specified in the inclusion criteria. Therefore, the patient does not meet this criterion.\n\n2. Diastolic blood pressure: The patient note does not mention the patient's diastolic blood pressure, but it does mention that the patient has hypertension, which is a major disease. Therefore, the patient does not meet this criterion.\n\n3. Free of major disease: The patient note mentions that the patient has hypertension, which is a major disease. Therefore, the patient does not meet this criterion.\n\n4. Not on a special diet or antihypertensive medication at entry: The patient note mentions that the patient is known to have hypertension and currently takes no medications. Therefore, the patient does not meet this criterion.\n\n5. Some mild to moderately obese subjects: The patient note mentions that the patient is obese, which meets this criterion.\n\nBased on the above assessment, I would not refer this patient for this clinical trial.\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.<|eot_id|>",
        "label": 0
    },
    "3": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\nPatient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nInclusion criteria:\nEthnicity: Black\nAge: 18-70 years\nMedical History: Healthy, no established coronary artery disease, no diabetes\nExclusion criteria:\nBlack Ethnicity other than American or African\nDiabetes\nMedications that alter the parameters under investigation\nPregnant or Breastfeeding\nMenstrual History: Women on injectable hormonal contraception\n\nAssessment of eligibility:\nThe patient is an African-American woman, which meets the ethnicity criterion. Her age is 58, which falls within the age range of 18-70 years. She has a medical history of hypertension and obesity, but no established coronary artery disease or diabetes. She is not taking any medications that alter the parameters under investigation, and she is not pregnant or breastfeeding. Her menstrual history is not relevant to the exclusion criteria.\n\nTrial-level eligibility: 2) Highly likely to refer this patient for this clinical trial.<|eot_id|>",
        "label": 0
    },
    "4": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. African American: The patient is an African-American woman, which meets the inclusion criterion.\n2. Age: The patient is 58 years old, which falls within the age range of 29-85 years old, meeting the inclusion criterion.\n3. Non-cardioembolic ischemic stroke: The patient presents with episodic pressing/burning anterior chest pain, which is not specifically mentioned as a stroke. However, the patient note does not rule out the possibility of a stroke. Therefore, we cannot determine if the patient meets this criterion.\n4. Onset of entry stroke at least 7 days but no more than 90 days: The patient's symptoms started two days ago, which is within the time frame specified in the inclusion criterion.\n5. CT or MRI following entry stroke and consistent with occurrence of entry stroke: The patient note does not mention a CT or MRI scan, so we cannot determine if the patient meets this criterion.\n6. Measurable neurologic deficit that correlates with onset of entry stroke: The patient note does not mention any measurable neurologic deficit, so we cannot determine if the patient meets this criterion.\n7. Informed consent: The patient is able to provide informed consent, meeting the inclusion criterion.\n8. Able to follow outpatient treatment program: The patient is able to follow an outpatient treatment program, meeting the inclusion criterion.\n\nBased on the assessment, I would say:\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.<|eot_id|>",
        "label": 0
    },
    "5": {
        "output": "Let's go through the patient note and the clinical trial inclusion criteria step by step.\n\nThe patient note describes a 58-year-old African-American woman with episodic anterior chest pain, hypertension, and obesity. She has no known history of smoking, diabetes, hypercholesterolemia, or a family history of heart disease.\n\nThe clinical trial, Muscatine Heart Study, has no specified inclusion criteria. This means that the trial is open to all patients who meet the general criteria for participation in a clinical trial, which typically includes being at least 18 years old and able to provide informed consent.\n\nBased on the patient note, the patient is an adult and appears to be able to provide informed consent. Therefore, I would assess her eligibility for the clinical trial as follows:\n\n* Would not refer this patient for this clinical trial: 0)<|eot_id|>",
        "label": 2
    },
    "6": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. The patient is an African-American woman, which matches the inclusion criterion \"African American\".\n2. The patient is not a resident of Jackson, Mississippi, which does not match the inclusion criterion \"Residents of Jackson, Mississippi\".\n\nBased on these factors, I would assess the patient's eligibility as follows:\n\nAssessment of eligibility: 0) Would not refer this patient for this clinical trial.\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.<|eot_id|>",
        "label": 2
    },
    "7": {
        "output": "Let's go through the patient note and the clinical trial inclusion criteria step by step.\n\nThe patient is a 58-year-old African-American woman, which matches the demographic criteria of the clinical trial.\n\nThe patient presents with episodic chest pain, which is not a specific inclusion criterion. However, the patient's symptoms are not related to the specific focus of the clinical trial, which is racial variation in ACE-genetic and physiologic bases.\n\nThe patient has hypertension and obesity, which are not specific inclusion criteria. However, these conditions are common in the general population and do not necessarily relate to the specific focus of the clinical trial.\n\nThe patient does not have a family history of heart disease, which is not a specific inclusion criterion.\n\nThe patient does not take any medications, which is not a specific inclusion criterion.\n\nBased on the patient's demographic characteristics and medical history, I would assess the patient's eligibility as follows:\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.<|eot_id|>",
        "label": 2
    },
    "8": {
        "output": "I'm ready to help. Let's go through the patient note and the inclusion criteria of the clinical trial step by step.\n\nPatient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Enoximone Plus Extended-Release Metoprolol Succinate in Subjects With Advanced Chronic Heart Failure\n\nInclusion criteria:\n1. Competent to provide informed written consent.\n2. 18 years of age or older.\n3. Ischemic or nonischemic cardiomyopathy with symptoms of NYHA Class III or IV chronic heart failure.\n4. LVEF of less than or equal to 35%, measured within 60 days of the Screening Visit.\n5. LVEDD of >2.7 cm/m2 as measured by 2-D ECHO within 12 months of the Screening Visit.\n6. On optimal conventional heart failure therapy (with the exception of a beta-blocker), including an ACEI for at least 30 days prior to the Screening Visit, or the subject must have had a trial of an ACEI and proven to be intolerant, or the subject must be taking an ARB for at least 30 days prior to the Screening Visit or proved to be intolerant.\n7. Failed the initiation, or the up-titration, of a beta-blocker drug due to hemodynamic intolerance within 12 months prior to the Screening Visit.\n\nExclusion criteria:\n(We will not consider exclusion criteria for now, as we are focusing on inclusion criteria.)\n\nLet's assess the patient's eligibility for the clinical trial:\n\n1. Competent to provide informed written consent: Yes, the patient is competent to provide informed written consent.\n2. 18 years of age or older: Yes, the patient is 58 years old, which is greater than 18 years old.\n3. Ischemic or nonischemic cardiomyopathy with symptoms of NYHA Class III",
        "label": 0
    },
    "9": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\nThe patient presents with episodic chest pain, which is not related to chronic back pain. The inclusion criteria specify chronic back pain for at least 6 months, which is not met in this case.\n\nThe patient does not have a history of treatment by medication or physical therapy for back pain, which is another inclusion criterion not met.\n\nBased on this assessment, I would not refer this patient for this clinical trial.\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.<|eot_id|>",
        "label": 0
    },
    "10": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. End-stage renal disease: The patient note mentions that the patient has hypertension and obesity, but it does not explicitly state that she has end-stage renal disease. However, it does mention that she is known to have hypertension, which could be a sign of kidney disease. I would assess this as 1) Would consider referring this patient to this clinical trial upon further investigation.\n\n2. Hemodialysis: The patient note does not mention hemodialysis, but it does mention that the patient is known to have hypertension and obesity, which could be indicative of kidney disease. I would assess this as 1) Would consider referring this patient to this clinical trial upon further investigation.\n\n3. Hypertension: The patient note mentions that the patient is known to have hypertension, which is an inclusion criterion. I would assess this as 2) Highly likely to refer this patient for this clinical trial.\n\n4. Written informed consent: The patient note does not mention written informed consent, but it does mention that the patient is presenting to the ER with symptoms. I would assess this as 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.<|eot_id|>",
        "label": 0
    },
    "11": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Clinical diagnosis of hypertension: The patient note mentions that the patient is known to have hypertension, which meets this criterion.\n2. Clinical diagnosis of type 2 diabetes or impaired glucose tolerance: The patient note does not mention a diagnosis of type 2 diabetes, but it does mention that the patient has episodic pressing/burning anterior chest pain that began two days earlier, which could be related to glucose intolerance. However, the patient note does not provide enough information to confirm or rule out impaired glucose tolerance.\n\nBased on the information provided, I would assess the patient's eligibility as follows:\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.<|eot_id|>",
        "label": 1
    },
    "12": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Age: The patient is 58 years old, which is below the age range of 65 years or older specified in the inclusion criteria. Therefore, the patient does not meet the age criterion.\n\n2. Current antihypertensive treatment with monotherapy: The patient is known to have hypertension and currently takes no medications. Therefore, the patient does not meet this criterion.\n\n3. SBP \u2265 140mmHg or DBP \u2265 90mmHg: The patient note does not mention the patient's blood pressure measurements. However, since the patient is known to have hypertension, it is likely that their blood pressure is above the specified levels.\n\n4. At least one of the following risk factors: The patient note does not mention any of the specified risk factors, such as diabetes, cerebral infarction, myocardial infarction, angina pectoris, heart failure, left ventricular hypertrophy, aortic aneurysm, aortic dissection, or arteriosclerotic peripheral arterial obstruction.\n\n5. Serum creatinine: The patient note does not mention the patient's serum creatinine level.\n\n6. Proteinuria: The patient note does not mention the patient's proteinuria level.\n\nBased on the above assessment, I would not refer this patient for this clinical trial.\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.<|eot_id|>",
        "label": 0
    },
    "13": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. The patient has essential hypertension, which is mentioned in the inclusion criteria.\n2. The patient's SBP (systolic blood pressure) is not mentioned in the patient note, but the inclusion criteria specify a range of 140-159 mmHg. Since the patient note does not provide the exact value, we cannot determine if the patient's SBP falls within this range.\n3. The patient's DBP (diastolic blood pressure) is not mentioned in the patient note, but the inclusion criteria specify a range of 90-99 mmHg. Since the patient note does not provide the exact value, we cannot determine if the patient's DBP falls within this range.\n\nBased on the information provided, I would assess the patient's eligibility as follows:\n\nAssessment of eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.<|eot_id|>",
        "label": 1
    },
    "14": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Age: The patient is 58 years old, which meets the inclusion criteria of being \u226518 years of age.\n2. Diagnosis: The patient has episodic pressing/burning anterior chest pain, which is consistent with angina pectoris, a type of clinically stable angina.\n3. Symptom status: The patient has symptomatic myocardial ischemia, as the pain is accompanied by nausea, diaphoresis, and mild dyspnea.\n4. Previous treatment history: The patient takes no medications, which is not relevant to the inclusion criteria.\n5. Other medical conditions: The patient has hypertension and obesity, but these conditions are not relevant to the inclusion criteria.\n\nBased on the above assessment, I would say:\n\nTrial-level eligibility: 2) Highly likely to refer this patient for this clinical trial.<|eot_id|>",
        "label": 2
    },
    "15": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Clinical diagnosis of hypertension: The patient note mentions that the patient is known to have hypertension, which meets this criterion.\n2. Clinical diagnosis of one or more risk factors: The patient note mentions that the patient has hypertension, obesity (BMI>25), and is known to have hypertension, which meets this criterion.\n\nHowever, the patient note does not mention any other risk factors such as diabetes, smoking habit, lipid metabolism abnormality, history of ischemic heart disease (IHD) or cerebrovascular disease, or electrocardiogram (ECG) abnormality (LVH).\n\nBased on this assessment, I would say:\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.<|eot_id|>",
        "label": 1
    },
    "16": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. History of diabetes for at least 5 years: The patient note does not mention a history of diabetes, so this criterion is not met.\n2. At least 2 risk factors: The patient note mentions hypertension and obesity, which are both risk factors. However, the patient does not have diabetes, which is a required risk factor.\n3. Atypical chest pain: The patient note describes the patient's chest pain as \"episodic pressing/burning anterior chest pain\", which is not specified as atypical.\n\nBased on the above assessment, I would not refer this patient for this clinical trial.\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.<|eot_id|>",
        "label": 1
    },
    "17": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Age: The patient is 58 years old, which is outside the age range of 8-18 years old specified in the inclusion criteria. Therefore, the patient does not meet this criterion.\n\n2. Referrals for innocent heart murmurs: The patient note does not mention innocent heart murmurs, so this criterion is not applicable.\n\n3. Pediatric patients experiencing chest pain: The patient note mentions chest pain, but the patient is 58 years old, which is outside the pediatric age range. Therefore, the patient does not meet this criterion.\n\n4. English speaking: The patient note does not mention the patient's language proficiency, but it is likely that the patient is English speaking since she is presenting to an ER in the US. However, this criterion is not a strict requirement, and the patient may still be eligible if they are not English speaking.\n\nBased on the above assessment, I would not refer this patient for this clinical trial.\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.<|eot_id|>",
        "label": 0
    },
    "18": {
        "output": "I'd be happy to help! Let's go through the patient note and the inclusion criteria step by step.\n\nFrom the patient note, we can gather the following information:\n\n* The patient is a 58-year-old African-American woman.\n* She presents with episodic pressing/burning anterior chest pain that radiates to the back and is accompanied by nausea, diaphoresis, and mild dyspnea.\n* She has hypertension and obesity, but no other medical conditions mentioned.\n* She is not taking any medications.\n* The EKG shows nonspecific changes.\n\nFrom the inclusion criteria, we can see that the trial is looking for patients with HF or IHD who are not currently taking the study medications of interest (ACE inhibitors/angiotensin receptor blockers for HF or statins for IHD) and whose primary care physicians are part of the study population.\n\nBased on this information, I would assess the patient's eligibility as follows:\n\n* The patient's age, gender, and ethnicity do not seem to be relevant to the inclusion criteria.\n* The patient's symptoms, such as chest pain, nausea, diaphoresis, and mild dyspnea, are not specific to HF or IHD, and the EKG shows nonspecific changes, which does not suggest a diagnosis of HF or IHD.\n* The patient has hypertension and obesity, but no other medical conditions mentioned.\n* The patient is not taking any medications.\n\nConsidering these factors, I would assess the patient's eligibility as follows:\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.<|eot_id|>",
        "label": 2
    },
    "19": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Age: The patient is 58 years old, which is greater than 18 years of age, so she meets this criterion.\n2. Patients with high blood pressure: The patient presents to the ER with episodic pressing/burning anterior chest pain, which is a symptom of high blood pressure. She is also known to have hypertension, so she meets this criterion.\n\nBased on the patient note and the inclusion criteria, I would assess the patient's eligibility as follows:\n\nTrial-level eligibility: 2) Highly likely to refer this patient for this clinical trial.<|eot_id|>",
        "label": 0
    },
    "20": {
        "output": "I'd be happy to help! Let's go through the patient note and the inclusion criteria step by step.\n\n1. Hormonal therapy-resistant MBC: The patient note does not mention MBC (metastatic breast cancer), so we cannot determine if the patient meets this criterion.\n\n2. ER (-), failure of hormonal therapy for MBC, or relapse within 6 months after adjuvant hormonal therapy: The patient note does not mention ER status, hormonal therapy, or adjuvant hormonal therapy, so we cannot determine if the patient meets this criterion.\n\n3. No anthracyclines for MBC and no prior taxanes: The patient note does not mention anthracyclines or taxanes, so we cannot determine if the patient meets this criterion.\n\n4. At least 6 months from the completion of adjuvant chemotherapy: The patient note does not mention adjuvant chemotherapy, so we cannot determine if the patient meets this criterion.\n\n5. Measurable or evaluable lesions: The patient note does not mention any lesions, so we cannot determine if the patient meets this criterion.\n\n6. Age: 20 to 75 years: The patient is 58 years old, which falls within the age range.\n\n7. PS: 0-3: The patient note does not mention PS (performance status), so we cannot determine if the patient meets this criterion.\n\n8. WBC >= 4,000 /mm3 or ANC >=1,000 /mm3, Platelet >= 100,000 /mm3, SGOT/SGPT <= 1.5 x ULN, T-Bil <= 1.5 mg/dL, Cr <= 1.5 mg/dL: The patient note does not mention these laboratory values, so we cannot determine if the patient meets this criterion.\n\n9. Normal ECG: The patient note mentions a normal EKG, which meets this criterion.\n\n10. Written informed consent: The patient note does not mention informed consent, but it is assumed that the patient has given informed consent to be seen in the ER.\n\nBased on the above assessment, I would rate the patient's eligibility as:\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.<|eot_id|>",
        "label": 0
    },
    "21": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Chronic stable angina pectoris: The patient note mentions that the patient presents with episodic pressing/burning anterior chest pain, which is consistent with angina pectoris. However, it's not clear if the pain is chronic or stable. I would consider referring this patient to the clinical trial upon further investigation (1).\n\n2. Documented coronary artery disease: There is no mention of coronary artery disease in the patient note. I would not refer this patient for this clinical trial (0).\n\n3. Previous treatment with atenolol or other beta-blocker agent: The patient note mentions that the patient takes no medications, including beta-blockers. I would not refer this patient for this clinical trial (0).\n\n4. Exercise tolerance test positivity and stability: There is no mention of an exercise tolerance test in the patient note. I would consider referring this patient to the clinical trial upon further investigation (1).\n\nBased on the above assessment, I would output:\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.<|eot_id|>",
        "label": 0
    },
    "22": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Chronic stable angina: The patient note mentions that the patient presents with episodic pressing/burning anterior chest pain, which is consistent with chronic stable angina. **Eligible**\n2. Previous positive exercise tolerance test: The patient note does not mention a previous exercise tolerance test, so we cannot determine if the patient is eligible based on this criterion. **Not Eligible**\n3. Disease not suitable for coronary intervention: The patient note does not mention any coronary intervention, so we cannot determine if the patient is eligible based on this criterion. **Not Eligible**\n4. Do not have overt diabetes: The patient note mentions that the patient does not have diabetes, which is consistent with the inclusion criterion. **Eligible**\n5. Body mass index (BMI) greater than 25: The patient note mentions that the patient is obese, which is consistent with a BMI greater than 25. **Eligible**\n\nBased on the above assessment, I would rate the patient's eligibility as:\n\n**Trial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation**<|eot_id|>",
        "label": 1
    },
    "23": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Age: The patient is 58 years old, which meets the inclusion criteria of being 50 years old or older.\n2. Lumbar spine BMD (L1 to L4) T score: There is no mention of BMD or T score in the patient note, so we cannot determine if the patient meets this criterion.\n3. At least 3 years postmenopausal: The patient is not mentioned as being postmenopausal, so we cannot determine if she meets this criterion.\n\nBased on the patient note, we cannot determine if the patient meets the inclusion criteria for the clinical trial. Therefore, I would assess the patient's eligibility as:\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.<|eot_id|>",
        "label": 0
    },
    "24": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Age: The patient is 58 years old, which is above the upper limit of 55 years old specified in the inclusion criteria. Therefore, the patient does not meet the age criterion.\n\n2. Idiopathic mechanical low back pain (LBP): The patient presents with episodic pressing/burning anterior chest pain, which is not low back pain. Therefore, the patient does not meet the LBP criterion.\n\n3. LBP classified as sub-acute or chronic: The patient's LBP is not specified as sub-acute or chronic, and the patient's symptoms are not related to LBP. Therefore, the patient does not meet the LBP criterion.\n\n4. Written Informed Consent: This criterion is not relevant to the patient's eligibility, as it is a procedural requirement.\n\n5. Minimum baseline score on the Roland Morris Disability Questionnaire (RMQ) of 6 points: This criterion is not relevant to the patient's eligibility, as the patient does not have LBP.\n\nBased on the above assessment, I would not refer this patient for this clinical trial.\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.<|eot_id|>",
        "label": 0
    },
    "25": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Age: The patient is 58 years old, which is greater than 18 years old, so she meets this criterion.\n2. Admission to the ICCU with ACS: The patient presents to the ER with episodic pressing/burning anterior chest pain, which is consistent with ACS. She is admitted to the ICCU, so she meets this criterion.\n3. Presence of ischemic symptoms: The patient has ischemic symptoms (chest pain) during hospitalization, so she meets this criterion.\n4. Pain assessment: The patient's pain is described as pressing/burning anterior chest pain, but the pain assessment is not specifically mentioned. However, the patient's pain is severe enough to require hospitalization, so it's likely that the pain assessment would be greater than 3 out of 10. Therefore, the patient meets this criterion.\n5. Dynamic ECG findings: The patient's EKG shows nonspecific changes, but it does not specifically mention ST segment deviation or T wave inversion. Therefore, the patient does not meet this criterion.\n6. Willing and able to provide written informed consent: The patient is able to provide written informed consent, so she meets this criterion.\n\nBased on the above assessment, I would rate the patient's eligibility as:\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.<|eot_id|>",
        "label": 0
    },
    "26": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. The patient note mentions anterior chest pain, which is not related to pulmonary hypertension. The patient is also known to have hypertension, but this is not a specific diagnosis of pulmonary hypertension.\n\nAssessment: 0) Would not refer this patient for this clinical trial.\n\n2. The patient note does not mention any genetic analysis or clinical and hemodynamic profiles, which are important aspects of the clinical trial.\n\nAssessment: 0) Would not refer this patient for this clinical trial.\n\n3. The patient note does not mention a diagnosis of CTEPH (chronic thromboembolic pulmonary hypertension), which is a specific diagnosis required for the clinical trial.\n\nAssessment: 0) Would not refer this patient for this clinical trial.\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.<|eot_id|>",
        "label": 0
    },
    "27": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. The patient is an African-American woman, which matches the inclusion criteria of the clinical trial.\n2. The patient is 58 years old, which is not specified in the inclusion criteria, so we can't determine eligibility based on age.\n3. The patient is presenting with chest pain, which is not related to the clinical trial's focus on obesity and neighborhood environments.\n4. The patient has hypertension and obesity, which are relevant to the clinical trial's focus on obesity.\n5. The patient does not have any other medical conditions mentioned in the inclusion criteria (smoking, diabetes, hypercholesterolemia, or a family history of heart disease).\n6. The patient does not take any medications, which is not specified in the inclusion criteria.\n\nBased on the patient's characteristics, I would assess their eligibility as follows:\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.<|eot_id|>",
        "label": 0
    },
    "28": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Acute episode of chest pain of less than 7 days duration as primary reason for admission to a chest pain clinic.\nThe patient's chest pain started 2 days ago, which is within the 7-day duration. So, this criterion is met.\n\n2. Admitted to a chest pain clinic, suspected of acute coronary infarction, but with a negative diagnosis confirmed by normal coronary enzymes and normal ECG.\nThe patient was admitted to the ER with chest pain, but the EKG shows nonspecific changes, not a normal ECG. This criterion is not met.\n\n3. Pain arising from the thorax and/or neck.\nThe patient's pain is described as pressing/burning anterior chest pain, which arises from the thorax. This criterion is met.\n\n4. Able to read and understand Danish.\nThe patient's language is not specified in the note, but it's not Danish. This criterion is not met.\n\nBased on the assessment, I would not refer this patient for this clinical trial.\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.<|eot_id|>",
        "label": 2
    },
    "29": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\nThe patient is a 58-year-old African-American woman, which doesn't seem to be relevant to the inclusion criteria.\n\nThe patient presents with episodic pressing/burning anterior chest pain, which is not related to Prader-Willi syndrome or Early-onset Morbid Obesity.\n\nThe patient has hypertension and obesity, but this is not a specific requirement for the trial.\n\nThe patient denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease, which is not relevant to the trial.\n\nThe patient currently takes no medications, which is also not relevant to the trial.\n\nThe EKG shows nonspecific changes, which is not relevant to the trial.\n\nBased on the patient note, it seems that the patient does not have a confirmed diagnosis of Prader-Willi syndrome, nor does she have a documented medical history of her weight exceeding 150% of the ideal body weight or a body mass index greater than 97% before the age of 4 years.\n\nTherefore, I would assess the patient's eligibility as follows:\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.<|eot_id|>",
        "label": 0
    },
    "30": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Age: The patient is 58 years old, which is more than 10 years old, so she meets this criterion.\n2. Electrocardiographic diagnosis of SVT: The patient's EKG shows nonspecific changes, but it does not explicitly state SVT. However, the patient's symptoms, such as episodic pressing/burning anterior chest pain, radiating to the back, and accompanied by nausea, diaphoresis, and mild dyspnea, are consistent with SVT. Although the EKG is not diagnostic, the patient's symptoms suggest SVT, so I would consider this criterion met.\n3. SVT not converted by the vagal manoeuvres: There is no information in the patient note about vagal manoeuvres being attempted or not. Since this information is not available, I would not consider this criterion met.\n\nBased on the assessment, I would say:\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.<|eot_id|>",
        "label": 0
    },
    "31": {
        "output": "I'd be happy to help! Let's go through the patient note and the inclusion criteria step by step.\n\n1. Age: The patient is 58 years old, which is outside the age range of 15-40 years old specified in the inclusion criteria. Therefore, the patient does not meet this criterion.\n\n2. Gender: The patient is a female, which meets the inclusion criterion.\n\n3. First episode of spontaneous pneumothorax: The patient presents with a first episode of anterior chest pain, which is consistent with a first episode of spontaneous pneumothorax.\n\n4. Symptomatic or rim of air > 2cm on CXR requiring simple aspiration: The patient presents with symptomatic chest pain and dyspnea, which meets this criterion.\n\n5. Complete or nearly complete and persistent lung expansion immediately following manual aspiration: The patient's physical examination is normal, which suggests that the lung expansion is likely complete or nearly complete.\n\n6. Organ Function Requirements:\n\t* Hematological function: The patient's hemoglobin level is not mentioned in the patient note, but it is not a critical criterion for this trial.\n\t* Renal and hepatic functions: The patient's renal and hepatic functions are not mentioned in the patient note, but they are not critical criteria for this trial.\n\n7. Written inform consent: The patient's consent is not mentioned in the patient note, but it is a critical criterion for this trial.\n\nBased on the above assessment, I would rate the patient's eligibility as follows:\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.<|eot_id|>",
        "label": 0
    },
    "32": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Must have completed Visit 14/Week 24 of the NCT00046319 study.\n\t* The patient note does not mention the patient's participation in the NCT00046319 study, so this criterion is not met.\n\t* Assessment: 0) Would not refer this patient for this clinical trial.\n\n2. Women of childbearing potential must have a negative urine pregnancy test at the Screening/Enrollment Visit and agree to use a reliable double barrier method of contraception until study completion and for >=4 weeks following their final study visit.\n\t* The patient note does not mention the patient's reproductive status or pregnancy test results, so this criterion is not met.\n\t* Assessment: 0) Would not refer this patient for this clinical trial.\n\n3. Must have completed the Down-titration Period of NCT00046319 prior to enrollment in AMB-220-E and will meet the following additional criteria:\n\t* The patient note does not mention the patient's participation in the Down-titration Period of NCT00046319, so this criterion is not met.\n\t* Assessment: 0) Would not refer this patient for this clinical trial.\n\n4. Subjects with a diagnosis of HIV must have stable disease status at the time of Screening/Enrollment.\n\t* The patient note does not mention the patient's HIV status, so this criterion is not applicable.\n\t* Assessment: 0) Would not refer this patient for this clinical trial.\n\n5. Must be stable on conventional therapy for PAH for >=4 weeks prior to the Screening Visit.\n\t* The patient note does not mention the patient's treatment history or current therapy, so this criterion is not met.\n\t* Assessment: 0) Would not refer this patient for this clinical trial.\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.<|eot_id|>",
        "label": 0
    },
    "33": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Age: The patient is 58 years old, which is below the age range of 65 years or older specified in the inclusion criteria. Therefore, the patient does not meet the age criterion.\n\n2. Blood pressure: The patient's blood pressure is not mentioned in the patient note, but it is not a critical factor for this trial.\n\n3. Medical history or risk factors: The patient has hypertension, which is a risk factor. However, the patient does not have any other medical history or risk factors mentioned in the inclusion criteria.\n\nBased on the assessment, I would not refer this patient for this clinical trial.\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.<|eot_id|>",
        "label": 0
    },
    "34": {
        "output": "I'd be happy to help! Let's go through the patient note and the inclusion criteria step by step.\n\n1. Has chest pain as their primary complaint? - Yes, the patient presents to the ER with episodic pressing/burning anterior chest pain.\n\n2. Has an acute episode of pain of less than 7 days duration before admission? - Yes, the patient's pain started 2 days ago.\n\n3. Consents to the standardized evaluation program at the chest pain clinic. - Not applicable, as this is a patient note and not a clinical trial.\n\n4. Has pain in the thorax and/or neck. - Yes, the patient's pain radiates to the back and is accompanied by nausea, diaphoresis, and mild dyspnea.\n\n5. Can read and understand Danish. - Not applicable, as the patient is not from Denmark and the study is conducted in Denmark.\n\n6. Is between 18 and 75 years of age. - Yes, the patient is 58 years old.\n\n7. Is a resident of the Funen County. - Not applicable, as the patient's residence is not specified.\n\n8. Does not have any of the exclusion criteria. - The patient does not have ACS, PCI, CABG, inflammatory joint disease, insulin-dependent diabetes, fibromyalgia, malignant disease, apoplexy, dementia, or unable to cooperate. However, the patient has hypertension and obesity, which are not exclusion criteria.\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.<|eot_id|>",
        "label": 0
    },
    "35": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. The patient is a 58-year-old African-American woman, which does not meet the inclusion criterion of being male.\n2. The patient presents with episodic pressing/burning anterior chest pain, which is not specified as angina, and does not meet the inclusion criterion of having stable angina.\n3. The patient has hypertension and obesity, but these conditions are not exclusion criteria in this trial.\n4. The patient does not have a history of smoking, diabetes, hypercholesterolemia, or a family history of heart disease, which is good.\n5. The patient does not take any medications, which is also not an exclusion criterion.\n\nBased on the above assessment, I would not refer this patient for this clinical trial.\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.<|eot_id|>",
        "label": 1
    },
    "36": {
        "output": "I'm ready to help. Let's go through the patient note and the inclusion criteria of the clinical trial step by step.\n\nPatient note:\nA 58-year-old African-American woman presents to the ER with episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life. The pain started while she was walking, radiates to the back, and is accompanied by nausea, diaphoresis and mild dyspnea, but is not increased on inspiration. The latest episode of pain ended half an hour prior to her arrival. She is known to have hypertension and obesity. She denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease. She currently takes no medications. Physical examination is normal. The EKG shows nonspecific changes.\n\nClinical trial:\nTitle: Lapatinib in Combination With Weekly Paclitaxel in Patients With ErbB2 Amplified Advanced Gastric Cancer\n\nLet's start with the inclusion criteria:\n\n1. Signed informed consent: Not applicable (patient note does not mention informed consent)\n2. Male or female; \u2265 20 years (at the time of giving consent): The patient is a 58-year-old woman, so she meets this criterion.\n3. Any histologically or cytologically confirmed gastric carcinoma independent of tumor ErbB2 status: The patient note does not mention gastric carcinoma or ErbB2 status, so this criterion is not met.\n4. Subjects who have received one prior regimen for gastric carcinoma and developed disease progression or recurrence: The patient note does not mention gastric carcinoma or prior treatment, so this criterion is not met.\n5. Left ventricular ejection fraction (LVEF) within institutional range of normal as measured by echocardiogram (ECHO). Multigated acquisition (MUGA) scans will be accepted in cases where an echocardiogram cannot be performed or is inconclusive (LVEF of \u226550% required if normal range of LVEF is not provided by institution): The patient note does not mention LVEF or echocardiogram, so this criterion is not met.\n6. Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 to 1: The patient note does not mention ECOG Performance Status, so this criterion is not met.\n7. Able to swallow and retain oral medication: The patient note does not mention any medication, so this criterion is not met.\n8. Women and men with potential to have children must be willing to",
        "label": 0
    },
    "37": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\nThe patient note mentions that the patient is a 58-year-old African-American woman with hypertension and obesity. She also has no smoking, diabetes, hypercholesterolemia, or a family history of heart disease.\n\nThe inclusion criteria state that at least one modifiable cardiovascular risk factor is required. The patient has hypertension and obesity, which are both modifiable cardiovascular risk factors.\n\nBased on this information, I would assess the patient's eligibility as follows:\n\n* Would not refer this patient for this clinical trial: 0)<|eot_id|>",
        "label": 0
    },
    "38": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Biopsy-proven HL: The patient note does not mention Hodgkin Lymphoma (HL) or any biopsy results. Therefore, this criterion is not met.\n\nAssessment: 0) Would not refer this patient for this clinical trial.\n\n2. Participation in IRB-approved protocols for the first-line treatment of HL between 1975-2000: The patient note does not mention any treatment protocols or dates. Therefore, this criterion is not met.\n\nAssessment: 0) Would not refer this patient for this clinical trial.\n\n3. English speaking: The patient note does not mention any language barriers or difficulties. Therefore, this criterion is met.\n\nAssessment: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.<|eot_id|>",
        "label": 0
    },
    "39": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Age: The patient is 58 years old, which is within the age range of 18-65 years specified in the inclusion criteria.\n2. Investigated for chest pain or palpitation 6 months ago: The patient presents to the ER with episodic pressing/burning anterior chest pain, which suggests that she has been investigated for chest pain recently. However, the note does not specify that she was investigated 6 months ago at Cardiological Out-patient Clinic, Molde Hospital. This criterion is not fully met.\n3. Suffering from chest pain or palpitations: The patient is currently experiencing chest pain, which meets this criterion.\n\nBased on the assessment, I would say:\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.<|eot_id|>",
        "label": 0
    },
    "40": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Digital gangrene, ulcers in patients with severe secondary Raynaud's phenomenon:\nThe patient note does not mention digital gangrene or ulcers, nor does it mention Raynaud's phenomenon. Therefore, this criterion is not met.\n\n2. Stable therapy with vasoactive drugs, such as calcium channel blockers, angiotensin inhibitors/AT II receptor antagonists or pentoxifyllin 4 weeks before and during the treatment with sildenafil:\nThe patient note does not mention any vasoactive drugs or therapy. Therefore, this criterion is not met.\n\n3. Unchanged immunosuppressive therapy 3 months before treatment with sildenafil:\nThe patient note does not mention immunosuppressive therapy. Therefore, this criterion is not met.\n\n4. No effect of prostacyclin treatment, contraindications for prostacyclins, or other reasons excluding this therapy:\nThe patient note does not mention prostacyclin treatment. Therefore, this criterion is not met.\n\nBased on the above assessment, I would not refer this patient for this clinical trial.\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.<|eot_id|>",
        "label": 0
    },
    "41": {
        "output": "I'd be happy to help! Let's go through the patient note and the inclusion criteria step by step.\n\n1. DISEASE CHARACTERISTICS:\nThe patient has a diagnosis of malignant pleural effusion requiring pleurodesis, which is confirmed by the presence of nonspecific changes on the EKG. This meets the inclusion criteria.\n\n2. PATIENT CHARACTERISTICS:\nThe patient is 58 years old, which is within the age range not specified in the inclusion criteria. The patient is an African-American woman, which is also not specified in the inclusion criteria. The patient has hypertension and obesity, but these are not exclusion criteria. The patient is not pregnant or nursing, which meets the inclusion criteria. The patient has no history of GI bleeding or untreated peptic ulceration, which meets the inclusion criteria. The patient has no known sensitivity to NSAIDs, opiates, or paracetamol, which meets the inclusion criteria. The patient has no hypercapnic respiratory failure, which meets the inclusion criteria. The patient has no known intravenous drug abuse, which meets the inclusion criteria. The patient has no severe renal or liver disease, which meets the inclusion criteria. The patient has no known bleeding diathesis, which meets the inclusion criteria. The patient is able to give informed consent, which meets the inclusion criteria.\n\n3. PRIOR CONCURRENT THERAPY:\nThe patient is not taking any medications, which meets the inclusion criteria.\n\nBased on the patient note and the inclusion criteria, I would assess the patient's eligibility as follows:\n\nTrial-level eligibility: 2) Highly likely to refer this patient for this clinical trial.<|eot_id|>",
        "label": 0
    },
    "42": {
        "output": "I'd be happy to help! Let's go through the patient note and the inclusion criteria step by step.\n\n1. Age: The patient is 58 years old, which meets the inclusion criterion of being over 18 years of age.\n2. Gender: The patient is a woman, which meets the inclusion criterion of being a man or woman.\n3. IHD event: The patient presents to the ER with episodic pressing/burning anterior chest pain, which is consistent with an IHD event (acute coronary syndrome).\n4. Low or moderate risk: The patient's risk level is not specified in the patient note, but it is not explicitly mentioned that they are at high risk, so we can assume they are at low or moderate risk.\n5. Regular Internet access: The patient has regular access to the Internet, which meets the inclusion criterion.\n6. No physical limitations to regular activity: The patient's physical examination is normal, and they do not have any physical limitations that would prevent them from participating in regular activity.\n7. Ability to read, write, and understand English: The patient's language is not specified in the patient note, but it is assumed that they can read, write, and understand English without difficulty.\n\nBased on these factors, I would assess the patient's eligibility for the clinical trial as follows:\n\nTrial-level eligibility: 2) Highly likely to refer this patient for this clinical trial.<|eot_id|>",
        "label": 2
    },
    "43": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. The patient has a new onset of chest pain, which is not related to the clinical trial's focus on Type 2 Diabetes.\n2. The patient's BMI is not mentioned in the patient note, but we can infer that it is likely to be above 25 kg/m2 based on her obesity.\n3. The patient has hypertension, but this is not an exclusion criterion in the clinical trial.\n4. The patient has no history of smoking, diabetes, hypercholesterolemia, or a family history of heart disease, which is good.\n\nBased on the above assessment, I would rate the patient's eligibility as follows:\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.<|eot_id|>",
        "label": 0
    },
    "44": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. The patient note mentions that the patient has episodic pressing/burning anterior chest pain, which is not related to metastatic breast cancer. Therefore, the patient does not meet the inclusion criteria.\n\n2. The patient note does not mention any history of breast cancer, metastatic or otherwise. Therefore, the patient does not meet the inclusion criteria.\n\nBased on the above, I would assess the patient's eligibility as follows:\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.<|eot_id|>",
        "label": 0
    },
    "45": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Clinical diagnosis of COPD: The patient note mentions that the patient presents with episodic pressing/burning anterior chest pain, which is not directly related to COPD. However, it does not rule out the possibility of COPD. I would consider referring this patient to this clinical trial upon further investigation.\n\n2. > 40 years of age: The patient is 58 years old, which meets this criterion.\n\n3. > 15 pack year smoking history: The patient note does not mention the patient's smoking history, but it does mention that she denies smoking. Therefore, this criterion is not met.\n\nBased on the assessment, I would output:\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.<|eot_id|>",
        "label": 0
    },
    "46": {
        "output": "I'd be happy to help! Let's go through the patient note and the inclusion criteria step by step.\n\nFirst, let's look at the patient's age. The patient is 58 years old, which is outside the age range specified in the inclusion criteria (20-55 years old). This is a significant deviation from the inclusion criteria.\n\nNext, let's look at the patient's symptoms. The patient presents with episodic pressing/burning anterior chest pain, which is not related to low back pain. The inclusion criteria specifically state that patients must have low back pain.\n\nFinally, let's look at the patient's treatment history. The patient is known to have hypertension and obesity, but there is no mention of physical therapy treatment for low back pain.\n\nBased on these factors, I would assess the patient's eligibility as follows:\n\nAssessment of eligibility: 0) Would not refer this patient for this clinical trial.\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.<|eot_id|>",
        "label": 0
    },
    "47": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Current substance abuse: The patient note does not mention any substance abuse, so this criterion is not met.\n\nAssessment: 0) Would not refer this patient for this clinical trial.\n\n2. Current high-risk sexual behavior: The patient note does not mention any high-risk sexual behavior, so this criterion is not met.\n\nAssessment: 0) Would not refer this patient for this clinical trial.\n\n3. African American racial identification: The patient note states that the patient is an African-American woman, so this criterion is met.\n\nAssessment: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.<|eot_id|>",
        "label": 0
    },
    "48": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Age: The patient is 58 years old, which falls within the age range of 18-80 years specified in the inclusion criteria.\n\n2. Gender: The patient is a female, which is also specified in the inclusion criteria.\n\n3. Coronary artery disease: The patient has a history of hypertension and obesity, but there is no mention of a well-documented medical history of myocardial infarction or significant coronary artery disease. Therefore, this criterion is not met.\n\n4. Symptoms: The patient presents with episodic pressing/burning anterior chest pain, which is accompanied by nausea, diaphoresis, and mild dyspnea. This could be consistent with symptoms of chronic angina, but it is not clear if the patient has a history of an abnormal exercise response limited by angina and/or electrocardiograph (ECG) changes.\n\n5. Angina pectoris: The patient's symptoms are consistent with moderate angina pectoris (Class II or Class III, Grading of Angina Pectoris by the Canadian Cardiovascular Society Classification System).\n\n6. Exercise tolerance: There is no information about the patient's exercise tolerance, including their Total Exercise Duration (TED) or the difference in TED between two screen examinations.\n\n7. Previous treatment: The patient is not taking any medications, and there is no information about previous anti-angina regimen or oral anticoagulants.\n\n8. Compliance: The patient is able to give voluntary written informed consent, and it is likely that they will be able to comply with all study procedures and restrictions.\n\nBased on the above assessment, I would rate the patient's eligibility as follows:\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.<|eot_id|>",
        "label": 1
    },
    "49": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. The patient is 58 years old, which is greater than 18 years old, so she meets the age criterion.\n2. The patient has objective evidence of systolic dysfunction, as she presents with episodic pressing/burning anterior chest pain, radiating to the back, and accompanied by nausea, diaphoresis, and mild dyspnea, which are symptoms consistent with heart failure. The EKG shows nonspecific changes, which could be indicative of systolic dysfunction. Therefore, she meets the criterion for objective evidence of systolic dysfunction.\n3. The patient is on stable optimal medical heart failure therapy, as she is not taking any medications. However, she has hypertension and obesity, which are conditions that may be related to heart failure. She is not taking any medications, which is consistent with the criterion of being on stable optimal medical heart failure therapy.\n\nBased on these factors, I would assess the patient's eligibility as follows:\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.<|eot_id|>",
        "label": 1
    },
    "50": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. The patient is a 58-year-old African-American woman, which is not a specific criterion for the trial.\n2. She presents with episodic chest pain, which is not a specific criterion for the trial.\n3. She has hypertension and obesity, which is relevant to the trial. The trial is looking at morbidly obese patients, and the patient meets this criterion.\n4. She has no history of smoking, diabetes, hypercholesterolemia, or a family history of heart disease, which is not a specific criterion for the trial.\n5. She currently takes no medications, which is not a specific criterion for the trial.\n\nBased on the patient note, the patient has hypertension and obesity, which makes her eligible for the trial. However, the trial is looking at the endothelial function in morbidly obese patients undergoing bariatric surgery, and the patient note does not mention any plans for surgery.\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.<|eot_id|>",
        "label": 1
    },
    "51": {
        "output": "I'd be happy to help! Let's go through the patient note and the inclusion criteria step by step.\n\n1. Age: The patient is 58 years old, which is not specified in the inclusion criteria. However, the inclusion criteria do not specify an age range, so this factor does not disqualify the patient.\n\n2. Gender: The patient is a woman, which is not specified in the inclusion criteria. However, the inclusion criteria do not specify a gender, so this factor does not disqualify the patient.\n\n3. Disease: The patient presents with episodic pressing/burning anterior chest pain, which is not specified in the inclusion criteria. However, the inclusion criteria do not specify a particular disease, so this factor does not disqualify the patient.\n\n4. Previous treatment history: The patient is known to have hypertension and obesity, but she currently takes no medications. This factor does not disqualify the patient.\n\n5. Other medical conditions: The patient has hypertension and obesity, but these conditions are not specified in the inclusion criteria. However, the inclusion criteria do specify morbid obesity, which the patient has.\n\nBased on the patient note and the inclusion criteria, I would assess the patient's eligibility as follows:\n\n* Would not refer this patient for this clinical trial (0)\n\nThe patient does not meet the inclusion criteria for the study, as she does not have morbid obesity and type 2 diabetes, and she is not a post-bariatric surgery patient. Additionally, the patient's symptoms and medical history do not match the study's focus on GIP infusion and adipose tissue metabolism.\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.<|eot_id|>",
        "label": 2
    },
    "52": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. The patient has a diagnosis of heart failure, which is mentioned in the patient note as \"episodic pressing/burning anterior chest pain that began two days earlier for the first time in her life\". This meets the inclusion criteria of \"Randomised control trials of beta-blocker versus control in patients with documented heart failure\".\n\n2. The patient is a woman, which is a specific sub-population mentioned in the inclusion criteria as one of the groups that may show particular benefit from beta-blockers.\n\n3. The patient is 58 years old, which is also a specific sub-population mentioned in the inclusion criteria as one of the groups that may show particular benefit from beta-blockers.\n\n4. The patient has hypertension and obesity, which are not mentioned in the inclusion criteria as exclusion criteria, so they do not affect the patient's eligibility.\n\n5. The patient does not have diabetes, hypercholesterolemia, or a family history of heart disease, which are not mentioned in the inclusion criteria as exclusion criteria, so they do not affect the patient's eligibility.\n\n6. The patient is not taking any medications, which is not mentioned in the inclusion criteria as an exclusion criterion, so it does not affect the patient's eligibility.\n\n7. The patient's EKG shows nonspecific changes, which is not mentioned in the inclusion criteria as an exclusion criterion, so it does not affect the patient's eligibility.\n\nBased on the above assessment, I would rate the patient's eligibility as:\n\nTrial-level eligibility: 2) Highly likely to refer this patient for this clinical trial.<|eot_id|>",
        "label": 2
    },
    "53": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. The patient note describes a 58-year-old African-American woman with episodic chest pain, hypertension, and obesity. However, there is no mention of acromio-clavicular dislocation or any relevant medical history related to the inclusion criteria.\n2. The inclusion criteria specify that the patient should have Tossy grade 3 AC-dislocation, which is not mentioned in the patient note.\n3. The patient note does not mention any relevant medical history or treatment history that would make them eligible for the study.\n\nBased on the assessment, I would rate the patient's eligibility as:\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.<|eot_id|>",
        "label": 0
    },
    "54": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Age: The patient is 58 years old, which is above the age range of 0-17 years specified in the inclusion criteria. Therefore, the patient does not meet the age criterion.\n\n2. Cardiopulmonary bypass: The patient is undergoing cardiopulmonary bypass for elective surgical correction of a congenital heart defect. However, the patient note does not mention any congenital heart defect or surgical correction.\n\n3. Taking an ACE inhibitor prior to operation: The patient note does not mention the patient taking any medications, including ACE inhibitors.\n\nBased on the above assessment, I would not refer this patient for this clinical trial.\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.<|eot_id|>",
        "label": 0
    },
    "55": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Age: The patient is 58 years old, which is outside the age range of 19-55 years old specified in the inclusion criteria. Therefore, the patient does not meet this criterion.\n\n2. Ability to walk without assistance: The patient presents with episodic pressing/burning anterior chest pain, which may affect her ability to walk without assistance. However, the patient note does not provide specific information about her ability to walk. Therefore, we cannot determine if she meets this criterion.\n\n3. Hearing acuity: The patient note does not provide information about the patient's hearing acuity. However, since the patient is able to communicate with the healthcare provider, it is likely that she has adequate hearing acuity.\n\n4. Visual acuity: The patient note does not provide information about the patient's visual acuity. However, since the patient is able to communicate with the healthcare provider, it is likely that she has adequate visual acuity.\n\n5. Language: The patient note does not specify the patient's language proficiency. However, since the patient is able to communicate with the healthcare provider, it is likely that she is able to speak and comprehend English.\n\n6. Cognitive ability: The patient note does not provide information about the patient's cognitive ability. However, since the patient is able to communicate with the healthcare provider, it is likely that she has sufficient cognitive ability to follow instructions and provide informed consent.\n\nBased on the above assessment, I would rate the patient's eligibility as follows:\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.<|eot_id|>",
        "label": 0
    },
    "56": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Clinically confident diagnosis of malignant pleural effusion requiring pleurodesis:\nThe patient note does not mention a diagnosis of malignant pleural effusion. However, it does mention anterior chest pain that radiates to the back, which could be related to a pleural effusion. I would consider referring this patient to this clinical trial upon further investigation, so I would rate this as 1) Would consider referring this patient to this clinical trial upon further investigation.\n\n2. The diagnosis may be established by one of:\nThe patient note does not provide a histologically proven pleural malignancy or typical features of pleural malignancy seen on direct vision during thoracoscopy. However, it does mention that the patient has hypertension and obesity, which could be related to a pleural effusion. I would consider referring this patient to this clinical trial upon further investigation, so I would rate this as 1) Would consider referring this patient to this clinical trial upon further investigation.\n\n3. Pleural effusion in the context of histologically proven cancer elsewhere:\nThe patient note does not mention a histologically proven cancer elsewhere. However, it does mention that the patient is known to have hypertension and obesity, which could be related to a pleural effusion. I would consider referring this patient to this clinical trial upon further investigation, so I would rate this as 1) Would consider referring this patient to this clinical trial upon further investigation.\n\n4. Expected survival more than 1 month:\nThe patient note does not provide information about the patient's expected survival. However, the patient is 58 years old and has hypertension and obesity, which could affect her expected survival. I would consider referring this patient to this clinical trial upon further investigation, so I would rate this as 1) Would consider referring this patient to this clinical trial upon further investigation.\n\n5. Written informed consent:\nThe patient note does not provide information about whether the patient has given written informed consent. However, it does mention that the patient is presenting to the ER, which suggests that she may be willing to participate in a clinical trial. I would consider referring this patient to this clinical trial upon further investigation, so I would rate this as 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.<|eot_id|>",
        "label": 0
    },
    "57": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. The patient note mentions that the patient has hypertension, which is not an inclusion criterion. However, the patient note does not mention type 2 diabetes or pre-diabetes, which are the inclusion criteria for the clinical trial.\n\nAssessment: 0) Would not refer this patient for this clinical trial.\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.<|eot_id|>",
        "label": 0
    },
    "58": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Age: The patient is 58 years old, which is above the age of 18 years, so she meets this criterion.\n2. Arterial hypertension: The patient has hypertension, which is documented in her medical history. Her blood pressure is not specified in the patient note, but it is not a requirement for the trial. Therefore, she meets this criterion.\n3. Tolerance to ACE inhibitors: The patient does not take any medications, including ACE inhibitors. However, it is not specified in the patient note whether she has tried ACE inhibitors in the past and did not tolerate them. Therefore, we cannot determine her tolerance to ACE inhibitors based on this information.\n\nBased on the above assessment, I would say:\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.<|eot_id|>",
        "label": 0
    },
    "59": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Age: The patient is 58 years old, which is outside the age range of 20-49 years old specified in the inclusion criteria. Therefore, the patient does not meet this criterion.\n\n2. Pregnancy: The patient note does not mention pregnancy, which is a crucial criterion for this clinical trial. The patient is actually presenting to the ER with chest pain, not low back pain.\n\n3. Low back pain: The patient note does not mention low back pain, but rather chest pain. The patient does not meet this criterion.\n\n4. Healthy: The patient note mentions hypertension and obesity, which are not necessarily healthy conditions. However, the patient is otherwise normal on physical examination. It's difficult to determine if the patient is \"healthy\" based on this information.\n\nConsidering the above points, I would assess the patient's eligibility as follows:\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.<|eot_id|>",
        "label": 0
    },
    "60": {
        "output": "I'd be happy to help! Let's go through the patient note and the inclusion criteria step by step.\n\n1. Hemoglobin diagnosis of SS (two copies of the hemoglobin S gene), SC (one copy of the hemoglobin S gene and one copy of the hemoglobin C gene), or S-\u03b2 thalassemia (\u03b2+ or \u03b20): The patient note does not mention the patient's hemoglobin diagnosis, so we cannot determine eligibility based on this criterion.\n\nAssessment: 0) Would not refer this patient for this clinical trial.\n\n2. No clinically apparent ACS: The patient note mentions that the patient presents with episodic pressing/burning anterior chest pain, which could be related to ACS. However, the patient note does not provide enough information to determine if the patient has clinically apparent ACS.\n\nAssessment: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\n3. No prior participation in either part of the study: The patient note does not mention any prior participation in the study.\n\nAssessment: 0) Would not refer this patient for this clinical trial.\n\n4. sPLA2 level greater than 100 ng/mL within the same 24-hour window that coincides with fever and chest radiograph negative for new pulmonary infiltrate within the last 12 hours of the 24-hour window: The patient note does not mention the patient's sPLA2 level or fever.\n\nAssessment: 0) Would not refer this patient for this clinical trial.\n\n5. Fever greater than 38.0\u00ba C within the same 24-hour window that coincides with elevated sPLA2 level (greater than 100 ng/mL) and chest radiograph negative for new pulmonary infiltrate within the last 12 hours of the 24-hour window: The patient note does not mention the patient's fever.\n\nAssessment: 0) Would not refer this patient for this clinical trial.\n\n6. Chest radiograph negative for new pulmonary infiltrate within the last 12 hours of the 24-hour window of an abnormal sPLA2 level and fever: The patient note does not mention the patient's chest radiograph.\n\nAssessment: 0) Would not refer this patient for this clinical trial.\n\n7. Hemoglobin levels equal or less than 10 g/dL at time of study entry: The patient note does not mention the patient's hemoglobin levels.\n\nAssessment: 0) Would not refer this patient for this clinical trial.\n\n8. Informed consent of parent",
        "label": 0
    },
    "61": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Age: The patient is 58 years old, which meets the inclusion criteria of being 18 years or older.\n2. Symptoms: The patient presents with episodic pressing/burning anterior chest pain, which is consistent with acute coronary syndromes. This meets the inclusion criteria.\n3. Time of presentation: The patient presents to the ER with symptoms that started 2 days ago, which is outside the 6-hour window specified in the inclusion criteria. This does not meet the inclusion criteria.\n\nBased on the assessment, I would say:\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.<|eot_id|>",
        "label": 2
    },
    "62": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. The patient is a 58-year-old African-American woman, which means she is not a child (the age range for the trial is 7-13 years old). Therefore, she does not meet the age criterion.\n\n2. The patient has a medical condition (chest pain) and is taking no medications, which means she is not clinically well with no known chronic illness. Therefore, she does not meet the clinical well-being criterion.\n\n3. The patient is overweight (due to obesity), but the trial is for children who are overweight or obese. Therefore, she does not meet the BMI criterion.\n\nBased on the above assessment, I would not refer this patient for this clinical trial.\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.<|eot_id|>",
        "label": 0
    },
    "63": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Age: The patient is 58 years old, which is within the intermediate risk range for IHD.\n2. Gender: The patient is a woman, which is also within the intermediate risk range for IHD.\n3. Symptoms: The patient presents with episodic pressing/burning anterior chest pain, which is a symptom of IHD.\n4. Exercise stress test results: The patient has not undergone an exercise stress test, but the symptoms are consistent with IHD.\n\nBased on these factors, I would assess the patient's eligibility as follows:\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.<|eot_id|>",
        "label": 1
    },
    "64": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. At Visit 1 (study entry) patients must have a medical history and physical and neurological examinations that support a clinical diagnosis of acute low back pain that is felt down to the lower leg below the knee with the onset no longer than 30 days before Visit 1.\n\nThe patient note does not mention low back pain, but rather anterior chest pain. Therefore, this criterion is not met.\n\nAssessment: 0) Would not refer this patient for this clinical trial.\n\n2. At Visit 1 patients must report qualifying pain intensity scores.\n\nThe patient note does not mention pain intensity scores, but it does describe the patient's symptoms. However, the pain is not related to low back pain, which is the focus of the clinical trial.\n\nAssessment: 0) Would not refer this patient for this clinical trial.\n\n3. Patients must be appropriate candidates for treatment with oral opioid pain medication in the investigator's clinical judgment.\n\nThe patient note does not mention any previous treatment with opioids, but it does mention that the patient is known to have hypertension and obesity. However, this criterion is based on the investigator's clinical judgment, so it's difficult to assess without more information.\n\nAssessment: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\n4. Patients must be able to appropriately verbalize pain characteristics and to complete all protocol required measurements/assessments without assistance.\n\nThe patient note does not mention any difficulties with verbalizing pain characteristics or completing assessments. However, it does mention that the patient is able to provide a detailed description of her symptoms.\n\nAssessment: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\n5. Patients must be medically stable on the basis of physical examination, medical history, vital signs, and clinical laboratory tests performed at screening.\n\nThe patient note does not mention any abnormal vital signs or laboratory tests. However, it does mention that the patient's physical examination is normal.\n\nAssessment: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.<|eot_id|>",
        "label": 0
    },
    "65": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. The patient note mentions anterior chest pain, which is not related to the shoulder or the painful stiff shoulder mentioned in the inclusion criteria. Therefore, the patient does not meet the inclusion criteria.\n\n2. The patient note does not mention any information about the range of motion of the glenohumeral joint, which is a crucial criterion for the study.\n\nBased on the above assessment, I would not refer this patient for this clinical trial.\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.<|eot_id|>",
        "label": 0
    },
    "66": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Apnea and hypopnea index of more than 20 /hr, and treated with CPAP:\nThe patient note does not mention the apnea and hypopnea index, but it does not mention CPAP therapy either. Therefore, we cannot determine if the patient meets this criterion.\n\nAssessment: 0) Would not refer this patient for this clinical trial.\n\n2. Uncontrolled hypertension (defined as systolic blood pressure of more than 130 mmHg or diastolic blood pressure of more than 80 mmHg):\nThe patient note mentions that the patient has hypertension, but it does not provide specific blood pressure values. However, it does not mention that the patient's hypertension is controlled.\n\nAssessment: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.<|eot_id|>",
        "label": 0
    },
    "67": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Age: The patient is 58 years old, which falls within the age range of 18-80 years specified in the inclusion criteria.\n2. Informed consent: The patient is presenting to the ER, so it's likely that she will be able to provide informed consent if she meets the other inclusion criteria.\n3. Hypertension: The patient has hypertension, which is a specified inclusion criterion.\n4. Type-II-diabetes mellitus: The patient note does not mention type-II-diabetes mellitus, which is a specified inclusion criterion.\n\nBased on the patient note, it appears that the patient does not have type-II-diabetes mellitus, which is a major exclusion criterion. Therefore, I would assess the patient's eligibility as follows:\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.<|eot_id|>",
        "label": 0
    },
    "68": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Age: The patient is 58 years old, which is above the age of 18 years old, so she meets this criterion.\n2. CCT > 60 ml/min: There is no information about the patient's CCT (creatinine clearance) in the patient note, so we cannot determine if she meets this criterion.\n3. No IHD: The patient note does not mention any information about the patient's coronary heart disease (IHD) status, so we cannot determine if she meets this criterion.\n4. No hyper/hypoparathyroidism: There is no information about the patient's parathyroid function in the patient note, so we cannot determine if she meets this criterion.\n5. No active malignancy: There is no information about the patient's cancer status in the patient note, so we cannot determine if she meets this criterion.\n6. Not taking calcium, phosphate: There is no information about the patient's medication use in the patient note, so we cannot determine if she meets this criterion.\n\nBased on the information available, I would assess the patient's eligibility as follows:\n\n* Would not refer this patient for this clinical trial (0) because we cannot determine if she meets criteria 2, 3, 4, and 6.\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.<|eot_id|>",
        "label": 0
    },
    "69": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. The decision to randomize participants was made by a qualified physician or paramedic who was present at the time.\n\t* The patient note does not mention who made the decision to randomize the patient, but it does mention that the patient presented to the ER. Since the patient did not present via ambulance, this criterion is not met.\n\t* Assessment: 0) Would not refer this patient for this clinical trial.\n2. Participants were included in the study if they presented either via ambulance or to a center where PCI is not performed and met all of the following criteria:\n\t* The patient did not present via ambulance, so this criterion is not met.\n\t* Assessment: 0) Would not refer this patient for this clinical trial.\n3. Provided written informed consent before initiation of any study related procedures. Participants randomized in the ambulance may initially have signed an abridged version.\n\t* The patient note does not mention whether the patient signed informed consent, but it does mention that the patient is 58 years old and has hypertension and obesity. Since the patient is over 18 years old, this criterion is met.\n\t* Assessment: 1) Would consider referring this patient to this clinical trial upon further investigation.\n4. Aged \u226518 years at the time of randomization.\n\t* The patient is 58 years old, which meets this criterion.\n\t* Assessment: 1) Would consider referring this patient to this clinical trial upon further investigation.\n5. Had a presumed diagnosis of STE-ACS with onset of symptoms of >20 minutes and <12 hours with one or more of the following:\n\t* The patient's symptoms started 2 days ago, which is outside the time window specified in the inclusion criteria.\n\t* Assessment: 0) Would not refer this patient for this clinical trial.\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.<|eot_id|>",
        "label": 0
    },
    "70": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\nThe patient note describes a 58-year-old African-American woman with episodic chest pain, hypertension, and obesity. She has no history of smoking, diabetes, hypercholesterolemia, or a family history of heart disease.\n\nThe inclusion criteria for the clinical trial are: Positive bilateral conjunctival allergen challenge (CAC) reaction.\n\nSince the patient note does not mention anything about conjunctival allergen challenge or allergic conjunctivitis, it is unlikely that this patient would be eligible for this clinical trial.\n\nTherefore, I would assess the patient's eligibility as follows:\n\nAssessment of eligibility: 0) Would not refer this patient for this clinical trial.\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.<|eot_id|>",
        "label": 0
    },
    "71": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. The patient note mentions \"episodic pressing/burning anterior chest pain\" which is not specified as stable or unstable angina. However, the patient is known to have hypertension and obesity, which are not exclusion criteria.\n\n2. The patient note does not mention any coronary lesions being confirmed by angiography or PCI, which is an inclusion criterion.\n\n3. The patient note does not mention any history of PCI for main lesions, which is another inclusion criterion.\n\n4. The patient's blood pressure is not mentioned in the patient note, but the patient is known to have hypertension, which meets the blood pressure criterion.\n\nBased on the above assessment, I would say:\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.<|eot_id|>",
        "label": 1
    },
    "72": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. The patient is a 58-year-old African-American woman, which is not relevant to the inclusion criteria.\n2. The patient presents with episodic pressing/burning anterior chest pain, which is not relevant to the inclusion criteria.\n3. The patient has hypertension and obesity, which is relevant to the inclusion criteria. The patient's BMI is not specified in the patient note, but it is mentioned that she is known to have obesity, which means her BMI is likely to be over 25.0 kg/m2, meeting the first inclusion criterion.\n4. The patient is a non-smoker, which meets the second inclusion criterion.\n\nBased on the above assessment, I would say:\n\nTrial-level eligibility: 2) Highly likely to refer this patient for this clinical trial.<|eot_id|>",
        "label": 0
    },
    "73": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Diagnosis of unstable angina and non-Q wave myocardial infarction:\nThe patient note mentions that the patient presents with episodic pressing/burning anterior chest pain, which is consistent with unstable angina. However, there is no mention of non-Q wave myocardial infarction. I would rate this as 1) Would consider referring this patient to this clinical trial upon further investigation.\n\n2. Age 18-75 yr:\nThe patient is 58 years old, which falls within the age range. I would rate this as 2) Highly likely to refer this patient for this clinical trial.\n\n3. Diameter stenosis of coronary artery <70% diameter stenosis by visual estimation:\nThere is no information about the patient's coronary artery stenosis in the patient note. I would rate this as 0) Would not refer this patient for this clinical trial.\n\n4. Blood pressure >110/70 mmHg:\nThe patient note does not mention the patient's blood pressure. I would rate this as 0) Would not refer this patient for this clinical trial.\n\n5. Heart rate 60-100 bpm, No cardiac arrhythmias:\nThe patient note does not mention the patient's heart rate or cardiac arrhythmias. I would rate this as 0) Would not refer this patient for this clinical trial.\n\nBased on the above assessment, I would rate the patient's eligibility as:\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.<|eot_id|>",
        "label": 0
    },
    "74": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Age: The patient is 58 years old, which falls within the age range of 18-60 years old specified in the inclusion criteria. (Match)\n2. Procedure: The patient is presenting to the ER with chest pain, but there is no mention of undergoing any of the specified procedures (abdominoplasty, bilateral breast reduction, bilateral breast lift, bilateral brachioplasty, bilateral lateral thigh and buttocks lift, or any combination thereof). (Mismatch)\n3. Anticoagulant therapy: The patient is not taking any medications, including anticoagulant therapy. (Match)\n4. Compliance: The patient is able to provide written informed consent, and there is no indication that they would not be willing or able to comply with study follow-up procedures. (Match)\n\nBased on these factors, I would assess the patient's eligibility as follows:\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.<|eot_id|>",
        "label": 0
    },
    "75": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Is the patient an ischemic heart disease patient? The patient note mentions that the patient presents with episodic pressing/burning anterior chest pain, which radiates to the back, and is accompanied by nausea, diaphoresis, and mild dyspnea. This suggests that the patient may have ischemic heart disease, but it's not explicitly stated. I would consider referring this patient to this clinical trial upon further investigation, so I'll give a score of 1.\n\n2. Has the patient been given a loading or maintenance dose of clopidogrel and is in need of it for 1 or more month? The patient note doesn't mention the patient taking clopidogrel, but it does mention that the patient is known to have hypertension and is currently taking no medications. This suggests that the patient may not be taking clopidogrel. I would not refer this patient for this clinical trial, so I'll give a score of 0.\n\n3. Is the patient in need of additional drug for optimal BP control (aim blood pressure <130/90) or angina control? The patient note mentions that the patient has hypertension, but it doesn't mention the patient's current blood pressure or whether it's being controlled. The patient also presents with chest pain, which could be related to angina. I would consider referring this patient to this clinical trial upon further investigation, so I'll give a score of 1.\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.<|eot_id|>",
        "label": 1
    },
    "76": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Age: The patient is 58 years old, which is greater than 18 years old, so she meets this criterion.\n2. Hypertension: The patient has hypertension, which is mentioned in the patient note, and it is also an inclusion criterion.\n3. ACE-I related cough: The patient note does not mention ACE-I related cough, but it does mention that the patient has hypertension and has had to stop previous treatment due to cough. However, the patient note does not specify if the cough was related to ACE-I treatment. Therefore, I would assess this criterion as \"Would consider referring this patient to this clinical trial upon further investigation\" (1).\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.<|eot_id|>",
        "label": 0
    },
    "77": {
        "output": "I'm ready to help. Let's go through the patient note and the inclusion criteria of the clinical trial step by step.\n\n1. Histologically confirmed squamous cell carcinoma (with biopsy on the primary and / or lymph node metastases) of the oral cavity, oropharynx, hypopharynx, larynx supraglottix:\nThe patient note does not mention any information about the type of cancer or biopsy results. Therefore, I would not refer this patient for this clinical trial (0).\n\n2. Locally advanced disease, defined by one of the following criteria: any T, N +, M0 (excluding T1, N1), T3-4, N0, M0:\nThe patient note does not provide any information about the stage of the disease. Therefore, I would consider referring this patient to this clinical trial upon further investigation (1).\n\n3. Not cancer nasopharynx or paranasal sinuses or salivary glands:\nThe patient note does not mention any information about the location of the cancer. Therefore, I would consider referring this patient to this clinical trial upon further investigation (1).\n\n4. General conditions and associated diseases which does not allow to perform chemotherapy or radiotherapy in a radical view:\nThe patient note mentions hypertension and obesity, but these conditions do not necessarily preclude radical chemotherapy or radiotherapy. Therefore, I would consider referring this patient to this clinical trial upon further investigation (1).\n\n5. No other surgical treatments, chemotherapy or radiotherapy for cancer of head and neck or elsewhere, except non-melanoma skin cancer or in situ cervical cancer and other solid tumors for which radical treatment has been completed > three years prior to enrollment in the study and for which the patient has remained continuously free of disease:\nThe patient note does not mention any previous treatments for cancer. Therefore, I would consider referring this patient to this clinical trial upon further investigation (1).\n\n6. Accessibility to follow-up:\nThe patient note does not provide any information about the patient's ability to follow up. Therefore, I would consider referring this patient to this clinical trial upon further investigation (1).\n\n7. Signing of informed consent:\nThe patient note does not mention any information about informed consent. Therefore, I would consider referring this patient to this clinical trial upon further investigation (1).\n\n8. Interval between examinations of local staging and randomization, maximum 3 weeks\nInterval between randomization and initiation of treatment, maximum 2 weeks:\nThe patient note does not provide any information about the timing of examinations or",
        "label": 0
    },
    "78": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\nThe patient is a 58-year-old African-American woman with episodic chest pain, hypertension, and obesity. She is known to have hypertension and obesity, but there is no mention of acute renal failure (ARF) or the need for renal replacement therapy.\n\nThe inclusion criteria for the clinical trial are: \"all ICU patients requiring renal replacement therapy\".\n\nBased on this information, I would assess the patient's eligibility as follows:\n\n* The patient is not an ICU patient, so she does not meet the inclusion criteria.\n* There is no mention of ARF or the need for renal replacement therapy, so she does not meet the inclusion criteria.\n* Therefore, I would not refer this patient for this clinical trial.\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.<|eot_id|>",
        "label": 0
    },
    "79": {
        "output": "I'd be happy to help! Let's go through the patient note and the inclusion criteria step by step.\n\n1. Age: The patient is 58 years old, which falls within the age range of 35-75 years specified in the inclusion criteria.\n2. Angina: The patient presents with episodic pressing/burning anterior chest pain that radiates to the back, which is consistent with angina. The patient's angina is classified as Canada Cardiovascular Society Class II-IV, which meets the inclusion criteria.\n3. Essential Hypertension: The patient has hypertension, which is defined as taking at least 1 anti-hypertensive medication, or average systolic blood pressure \u2265140 mm Hg, or diastolic blood pressure \u226590 mmHg. The patient is known to have hypertension and is taking no medications, so this criterion is not met.\n4. ST-T changes of LVH: The patient's EKG shows nonspecific changes, but there is no mention of ST-T changes of LVH.\n5. ST-T changes of ischemia: The patient's EKG shows nonspecific changes, but there is no mention of ST-T changes of ischemia.\n6. Serum potassium: There is no mention of the patient's serum potassium level.\n7. Pregnancy test: The patient is a woman of child-bearing potential, but there is no mention of a pregnancy test.\n8. Willingness to comply with scheduled visits: There is no information about the patient's willingness to comply with scheduled visits.\n9. Informed consent form: There is no information about the patient's informed consent form.\n\nBased on the above assessment, I would rate the patient's eligibility as follows:\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.<|eot_id|>",
        "label": 1
    },
    "80": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Chronic low back pain for >6 months: The patient note doesn't mention the duration of her low back pain, so we can't determine if she meets this criterion. However, the patient note does mention that the patient has episodic pressing/burning anterior chest pain, which is not the same as low back pain. Therefore, I would assess this criterion as \"Would not refer this patient for this clinical trial\" (0).\n\n2. >3 pain episodes per week: The patient note doesn't mention the frequency of her pain episodes, so we can't determine if she meets this criterion. However, the patient note does mention that the patient has episodic pressing/burning anterior chest pain, which is not the same as low back pain. Therefore, I would assess this criterion as \"Would not refer this patient for this clinical trial\" (0).\n\n3. Waist circumferences \u2265102 cm for men or \u226588 cm for women: The patient note doesn't mention the patient's waist circumference, but it does mention that the patient is obese. Therefore, I would assess this criterion as \"Would consider referring this patient to this clinical trial upon further investigation\" (1).\n\n4. Willing and able to participate in regular exercise for 14 weeks: The patient note doesn't mention the patient's willingness or ability to participate in regular exercise, but it does mention that the patient is known to have hypertension and obesity, which could be relevant to her ability to participate in exercise. Therefore, I would assess this criterion as \"Would consider referring this patient to this clinical trial upon further investigation\" (1).\n\n5. Using pain medications to control low back pain: The patient note doesn't mention the patient's use of pain medications, but it does mention that the patient is known to have hypertension and obesity, which could be relevant to her use of pain medications. Therefore, I would assess this criterion as \"Would consider referring this patient to this clinical trial upon further investigation\" (1).\n\n6. Free of abnormal cardiovascular responses during a screening graded maximal walk test: The patient note doesn't mention the patient's cardiovascular responses during a screening graded maximal walk test, but it does mention that the patient has hypertension, which could be relevant to her cardiovascular responses. Therefore, I would assess this criterion as \"Would consider referring this patient to this clinical trial upon further investigation\" (1).\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.",
        "label": 0
    },
    "81": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Obesity: The patient note mentions that the patient is known to have obesity, which matches the inclusion criteria.\n2. Ischemic Heart Disease (IHD): The patient note mentions that the patient presents to the ER with episodic pressing/burning anterior chest pain, which is a symptom of IHD. The EKG shows nonspecific changes, which could be indicative of IHD. This matches the inclusion criteria.\n3. Signed informed consent: This is not mentioned in the patient note, but it's not a problem since the patient has not been approached for the study yet.\n\nBased on the above assessment, I would say:\n\nTrial-level eligibility: 2) Highly likely to refer this patient for this clinical trial.<|eot_id|>",
        "label": 2
    },
    "82": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Age: The patient is 58 years old, which meets the inclusion criteria of being 18 years or older.\n2. Written informed consent: This is not relevant to the patient's eligibility, as it's a requirement for participation in the trial, not a characteristic of the patient.\n3. Cancer diagnosis: The patient's symptoms and EKG findings suggest a possible cardiac issue, but there is no mention of ovarian cancer or exocrine pancreatic cancer, which are the specific types of cancer required by the inclusion criteria.\n\nBased on these factors, I would assess the patient's eligibility as follows:\n\nAssessment of eligibility: 0) Would not refer this patient for this clinical trial.\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.<|eot_id|>",
        "label": 0
    },
    "83": {
        "output": "I'd be happy to help! Let's go through the patient note and the inclusion criteria step by step.\n\n1. Age: The patient is 58 years old, which falls within the age range of 18 to 80 years old, so this criterion is met.\n\n2. Gender: The patient is a woman, which is also an acceptable gender for the study.\n\n3. Rome III criteria for Functional Chest Pain of Presumed Esophageal Origin: The patient presents with episodic pressing/burning anterior chest pain that began two days earlier, which is consistent with the Rome III criteria. However, the patient note does not mention a trial of antidepressant therapy, which is a requirement for the study. Therefore, this criterion is not fully met.\n\n4. Negative cardiac evaluation: The patient's EKG shows nonspecific changes, but there is no mention of a cardiac stress test or coronary angiogram. Therefore, this criterion is not fully met.\n\n5. Negative gastrointestinal evaluation: The patient note does not mention any gastrointestinal evaluation, so this criterion is not fully met.\n\nBased on the above assessment, I would rate the patient's eligibility as follows:\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.<|eot_id|>",
        "label": 0
    },
    "84": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Age: The patient is 58 years old, which is not specified in the inclusion criteria. However, the trial is not limited to a specific age range, so this criterion is not met.\n2. Gender: The patient is a woman, which is not specified in the inclusion criteria. However, the trial only includes men, so this criterion is not met.\n3. Obesity: The patient is known to have obesity, which is specified in the inclusion criteria. This criterion is met.\n4. Aspirin treatment: The patient currently takes no medications, which means she has not received aspirin treatment before inclusion. This criterion is met.\n5. Coronary exploration: The patient has not undergone coronary angiography or tomography coronary angiography, which is specified in the inclusion criteria. However, the patient presents with chest pain, which is similar to stable angina, so this criterion is partially met.\n6. Chest pain like stable angina: The patient presents with episodic pressing/burning anterior chest pain that radiates to the back, which is similar to stable angina. This criterion is partially met.\n\nBased on the above assessment, I would rate the patient's eligibility as follows:\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.<|eot_id|>",
        "label": 0
    },
    "85": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Diagnosis of cystic fibrosis (positive sweat test and/or presence of 2 disease-causing mutations in the CFTR gene): The patient note does not mention a diagnosis of cystic fibrosis, so this criterion is not met.\n\nAssessment: 0) Would not refer this patient for this clinical trial.\n\n2. Age > 18 years: The patient is 58 years old, which meets this criterion.\n\nAssessment: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\n3. Patient with chronic chest, neck, or back pain: The patient presents with episodic pressing/burning anterior chest pain, which meets this criterion.\n\nAssessment: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\n4. Written Informed Consent: This criterion is not relevant to the patient's eligibility, as it is a requirement for participation in the study.\n\nAssessment: N/A\n\n5. With health insurance: This criterion is not relevant to the patient's eligibility, as it is a requirement for participation in the study.\n\nAssessment: N/A\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.<|eot_id|>",
        "label": 0
    },
    "86": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\nThe patient note describes a 58-year-old African-American woman with episodic chest pain, hypertension, and obesity. However, there is no mention of allergic conjunctivitis or a conjunctival allergen challenge (CAC) reaction.\n\nThe inclusion criteria for the clinical trial are: Positive bilateral conjunctival allergen challenge (CAC) reaction.\n\nBased on the patient note, there is no indication of a CAC reaction, so the patient does not meet the inclusion criteria.\n\nTherefore, I would assess the patient's eligibility as:\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.<|eot_id|>",
        "label": 0
    },
    "87": {
        "output": "I'd be happy to help! Let's go through the patient note and the inclusion criteria step by step.\n\n1. Age: The patient is 58 years old, which is within the age range of 18 to 79 years specified in the inclusion criteria.\n2. Gender: The patient is a female, which is also within the inclusion criteria.\n3. Chronic stable angina: The patient presents with episodic pressing/burning anterior chest pain that is triggered by physical effort and relieved by rest, which is consistent with chronic stable angina.\n4. Coronary artery disease: The patient's EKG shows nonspecific changes, but there is no clear evidence of coronary artery disease. However, the patient has hypertension and obesity, which are risk factors for CAD.\n5. Type 2 diabetes mellitus: The patient does not have a documented history of T2DM, which is a requirement for the study.\n6. Antianginal medications: The patient is not taking any antianginal medications, which is not a concern since the patient is not yet on treatment.\n7. Contraception: The patient is a female of childbearing potential, but there is no information about her willingness to use highly effective contraception methods.\n\nBased on the patient note and the inclusion criteria, I would assess the patient's eligibility as follows:\n\n* Age: 1) Would consider referring this patient to this clinical trial upon further investigation\n* Gender: 1) Would consider referring this patient to this clinical trial upon further investigation\n* Chronic stable angina: 1) Would consider referring this patient to this clinical trial upon further investigation\n* Coronary artery disease: 0) Would not refer this patient for this clinical trial\n* Type 2 diabetes mellitus: 0) Would not refer this patient for this clinical trial\n* Antianginal medications: 1) Would consider referring this patient to this clinical trial upon further investigation\n* Contraception: 1) Would consider referring this patient to this clinical trial upon further investigation\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation<|eot_id|>",
        "label": 0
    },
    "88": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Documented diagnosis of asthma or COPD in accordance with guidelines:\nThe patient note mentions that the patient presents with episodic pressing/burning anterior chest pain, which is not specific to asthma or COPD. However, it does not rule out the possibility of having one of these conditions. I would consider referring this patient to this clinical trial upon further investigation. (1)\n\n2. Stable condition, defined as a disease without exacerbation for at least 1 month prior to study enrolment:\nThe patient note does not provide information about the patient's disease status prior to the current episode of pain. However, it does mention that the patient is known to have hypertension and obesity, which are not related to asthma or COPD. I would consider referring this patient to this clinical trial upon further investigation. (1)\n\n3. Mean HR in holter ECG recording of \u2265 60 bpm:\nThe patient note does not provide information about the patient's heart rate. However, it does mention that the EKG shows nonspecific changes, which could indicate an abnormal heart rate. I would consider referring this patient to this clinical trial upon further investigation. (1)\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.<|eot_id|>",
        "label": 0
    },
    "89": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Chronic stable angina: The patient note mentions that the patient presents with episodic pressing/burning anterior chest pain, which radiates to the back, and is accompanied by nausea, diaphoresis, and mild dyspnea. Although the patient has not been diagnosed with chronic stable angina, the symptoms are consistent with angina. However, the patient note does not mention any previous diagnosis or documentation of chronic stable angina. Therefore, I would assess this criterion as 1) Would consider referring this patient to this clinical trial upon further investigation.\n\n2. Abnormal Exercise Myocardial Perfusion Spect Scan with reversible and partially reversible ischemic changes: The patient note does not mention any information about the patient's Exercise Myocardial Perfusion Spect Scan. Therefore, I would assess this criterion as 0) Would not refer this patient for this clinical trial.\n\n3. Age: The patient is 58 years old, which falls within the age range of 25 to 65 years. Therefore, I would assess this criterion as 2) Highly likely to refer this patient for this clinical trial.\n\n4. Patient must understand and be willing, able and likely to comply with all study procedures and restrictions and comprehends the diary cards: The patient note does not provide any information about the patient's understanding or willingness to comply with study procedures. However, it is assumed that the patient is able to provide informed consent. Therefore, I would assess this criterion as 1) Would consider referring this patient to this clinical trial upon further investigation.\n\n5. Patient must be able to give voluntary written informed consent: The patient note does not provide any information about the patient's ability to provide informed consent. However, it is assumed that the patient is able to provide informed consent. Therefore, I would assess this criterion as 2) Highly likely to refer this patient for this clinical trial.\n\nBased on the above assessment, I would conclude that the patient is eligible for the clinical trial.\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.<|eot_id|>",
        "label": 1
    },
    "90": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\nThe patient is a 58-year-old African-American woman, which matches the inclusion criteria of \"men & women, all races & ethnicities\".\n\nThe patient presents with episodic pressing/burning anterior chest pain, which could be related to acute coronary syndrome or unstable angina, matching the inclusion criteria of \"Acute myocardial infarction, acute coronary syndrome, unstable angina\".\n\nHowever, the patient note does not explicitly state that the patient has had a heart attack or is experiencing symptoms of a heart attack. The patient's symptoms are described as \"episodic pressing/burning anterior chest pain\" which could be related to a heart attack, but it's not clear if the patient has already had a heart attack or is currently experiencing symptoms.\n\nGiven this uncertainty, I would assess the patient's eligibility as:\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.<|eot_id|>",
        "label": 1
    },
    "91": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Age: The patient is 58 years old, which is outside the age range of 18 to 50 years old specified in the inclusion criteria. Therefore, the patient does not meet this criterion.\n\n2. Ability to understand and sign informed consent: The patient is an adult and appears to be mentally competent, so this criterion is likely met.\n\n3. Willingness to participate in all aspects of the study: The patient is seeking medical attention and is willing to participate in the ER, so it's likely that they would be willing to participate in a clinical trial.\n\n4. BMI: The patient is described as obese, but the note does not provide a specific BMI value. However, the inclusion criteria specify a BMI of 40-45 or 30-39.9 plus one or more co-morbid diseases. Since the patient's BMI is not specified, we cannot determine if they meet this criterion.\n\n5. Co-morbid diseases: The patient has hypertension, which is one of the co-morbid diseases listed in the inclusion criteria. However, the patient does not have any other co-morbid diseases mentioned in the note.\n\n6. Ambulatory status: The patient is able to walk and does not require a walking aid, so this criterion is met.\n\n7. Medical health: The patient's medical health is stable, as evaluated by the ER physician, so this criterion is likely met.\n\n8. Primary care physician: The patient has a primary care physician, so this criterion is met.\n\n9. Failure of standard obesity therapy: The patient has not received any standard obesity therapy, so this criterion is not applicable.\n\n10. Reconstructive surgery: The patient is not planning to undergo any reconstructive surgery during the trial, so this criterion is met.\n\nBased on the above assessment, I would rate the patient's eligibility as follows:\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.<|eot_id|>",
        "label": 1
    },
    "92": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Essential hypertension: The patient note mentions that the patient is known to have hypertension, which matches the inclusion criterion.\n2. ACE inhibitors: The patient note does not mention the patient's current medication, but it does mention that she currently takes no medications. This means that she is not currently taking ACE inhibitors, which does not match the inclusion criterion.\n\nBased on these factors, I would assess the patient's eligibility as follows:\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.<|eot_id|>",
        "label": 0
    },
    "93": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Patient age: The patient is 58 years old, which is greater than 18 years old, so she meets this criterion.\n2. Self-identifies as African-American: The patient is an African-American woman, so she meets this criterion.\n3. Early survivorship phase: The patient has just presented to the ER with chest pain, but it's not clear how long she's been in survivorship. Since she's only 1-12 months post-completion of treatment, we can't determine if she meets this criterion yet. Let's give her a score of 1) Would consider referring this patient to this clinical trial upon further investigation.\n4. Receiving health care primarily through an HMO: We don't have information about the patient's healthcare provider or insurance status, so we can't determine if she meets this criterion. Let's give her a score of 1) Would consider referring this patient to this clinical trial upon further investigation.\n5. Patients with metastatic cancer or a second primary cancer: The patient has breast cancer, but we don't have information about the stage or whether it's metastatic. Let's give her a score of 1) Would consider referring this patient to this clinical trial upon further investigation.\n6. Breast cancer survivors with other major disabling medical, psychiatric, or substance abuse conditions: The patient has hypertension and obesity, but we don't have information about any other conditions. Let's give her a score of 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nNow, let's look at the peer navigator criteria:\n\n1. At least 25 years of age: The patient is 58 years old, so she doesn't meet this criterion.\n2. Previously participated in any type of research study: We don't have information about the patient's research participation history, so we can't determine if she meets this criterion.\n3. Has at least high school education: The patient's education level is not specified, so we can't determine if she meets this criterion.\n4. Has been diagnosed with breast cancer, currently in remission or eradicated: The patient has breast cancer, so she meets this criterion.\n5. Belongs to a breast cancer support group: We don't have information about the patient's support group participation, so we can't determine if she meets this criterion.\n6. Has a valid driver's license: We don't have information about the patient's driver's",
        "label": 0
    },
    "94": {
        "output": "I'd be happy to help! Let's go through the patient note and the inclusion criteria step by step.\n\n1. Age: The patient is 58 years old, which meets the inclusion criteria of being > 20 years old.\n2. Effort-induced angina: The patient presents with episodic pressing/burning anterior chest pain that is relieved by rest or nitroglycerin, which meets the inclusion criteria of having effort-induced angina.\n3. Coronary artery disease or previous myocardial infarction: The patient has no history of coronary artery disease or previous myocardial infarction, which does not meet the inclusion criteria.\n4. Exercise tolerance testing (ETT): The patient's EKG shows nonspecific changes, but it does not meet the inclusion criteria of having a positive ETT (ST-segment depression \u2265 1 mm compared with at rest, with or without limiting angina).\n5. Menopausal status: The patient is a woman, but her menopausal status is not specified. However, since she is 58 years old, it is likely that she is post-menopausal, which meets the inclusion criteria.\n6. Contraception: The patient's contraception status is not specified, but it is not a critical factor in this case.\n7. Written informed consent: The patient is able to provide written informed consent, which meets the inclusion criteria.\n\nBased on the above assessment, I would rate the patient's eligibility as follows:\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.<|eot_id|>",
        "label": 0
    },
    "95": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Age: The patient is 58 years old, which falls within the age range of 18-75 years specified in the inclusion criteria. (Match)\n2. Ischemic discomfort: The patient presents with episodic pressing/burning anterior chest pain that began two days earlier, which is consistent with ischemic discomfort. The pain started while she was walking and radiates to the back, which is also consistent with ischemic discomfort. (Match)\n3. Left bundle-branch block (LBBB) on ECG: The patient's EKG shows nonspecific changes, but it does not explicitly state the presence of LBBB. However, since the patient is presenting with chest pain and LBBB is a possible diagnosis, we can assume that LBBB might be present. (Possible match)\n4. Urgent coronary angiography: The patient is presenting to the ER with chest pain, which suggests that urgent coronary angiography might be necessary. However, the patient note does not explicitly state that the patient has undergone urgent coronary angiography or PCI.\n\nBased on the above assessment, I would rate the patient's eligibility as follows:\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.<|eot_id|>",
        "label": 0
    },
    "96": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. The patient is a 58-year-old African-American woman, which meets the age criteria (age at the onset of the disease <50 or >60 years).\n2. The patient presents with episodic pressing/burning anterior chest pain, which could be related to a history of IHD (ischemic heart disease).\n3. The patient has a history of hypertension and obesity, but no other cardiovascular risk factors mentioned in the note (e.g., smoking, diabetes, hypercholesterolemia, or a family history of heart disease).\n4. The patient's EKG shows nonspecific changes, which could be related to a cardiac issue.\n\nBased on the patient note, I would assess the patient's eligibility as follows:\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.<|eot_id|>",
        "label": 0
    },
    "97": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. The patient presents with anterior chest pain, which is not related to the sacroiliac joint pain specified in the inclusion criteria. Therefore, the patient does not meet the inclusion criteria for this clinical trial.\n\n2. The patient's pain radiates to the back, which is not a specific requirement in the inclusion criteria.\n\n3. The patient has hypertension and obesity, but these are not exclusion criteria in the clinical trial.\n\n4. The patient denies smoking, diabetes, hypercholesterolemia, or a family history of heart disease, which is not relevant to the inclusion criteria.\n\n5. The patient currently takes no medications, which is not relevant to the inclusion criteria.\n\n6. The patient's physical examination is normal, which is not relevant to the inclusion criteria.\n\n7. The EKG shows nonspecific changes, which is not relevant to the inclusion criteria.\n\nBased on the patient note, I would assess the patient's eligibility for the clinical trial as follows:\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.<|eot_id|>",
        "label": 0
    },
    "98": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Diagnosis of POAG: The patient note does not mention POAG, but it does mention anterior chest pain, which is not related to glaucoma. Therefore, the patient does not meet this criterion.\n\nAssessment: 0) Would not refer this patient for this clinical trial.\n\n2. Documented glaucomatous VF damage with mean defect (MD) > 3 dB: As mentioned earlier, the patient note does not mention POAG or VF damage, so this criterion is not met.\n\nAssessment: 0) Would not refer this patient for this clinical trial.\n\n3. Progressing glaucomatous damage justifying a DSCI: The patient note does not mention glaucoma or any damage that would justify a DSCI.\n\nAssessment: 0) Would not refer this patient for this clinical trial.\n\n4. Aged \u226518 years, of either sex: The patient is 58 years old, which meets this criterion.\n\nAssessment: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\n5. Not more than 4 diopters spherical equivalent on the study eye: The patient note does not mention the patient's refractive error, so this criterion is unclear.\n\nAssessment: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\n6. Not more than 2 diopters cylinder equivalent on the study eye: Same as above, the patient note does not mention the patient's refractive error, so this criterion is unclear.\n\nAssessment: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\n7. Have given written informed consent, prior to any investigational procedures: The patient note does not mention informed consent, so this criterion is unclear.\n\nAssessment: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.<|eot_id|>",
        "label": 0
    },
    "99": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. The patient has episodic pressing/burning anterior chest pain, which is not related to the inclusion criteria of lower back pain and/or posterior pelvic pain.\n2. The patient's gestational age is not mentioned in the patient note, as she is not pregnant. The inclusion criteria specify that the gestational age must be greater than or equal to 12 weeks, which is not applicable to this patient.\n\nBased on these factors, I would assess the patient's eligibility as follows:\n\nTrial-level eligibility: 0) Would not refer this patient for this clinical trial.<|eot_id|>",
        "label": 0
    },
    "100": {
        "output": "Let's go through the patient note and the inclusion criteria step by step.\n\n1. Inappropriate sinus tachycardia (HR >100 bpm at rest ECG and/or medium Holter ECG HR >90 bpm):\nThe patient's EKG shows nonspecific changes, but it does not mention a heart rate of >100 bpm at rest or a medium Holter ECG HR >90 bpm. Therefore, the patient does not meet this criterion.\n\nAssessment of eligibility: 0) Would not refer this patient for this clinical trial.\n\n2. Age > 18 years:\nThe patient is 58 years old, which is greater than 18 years. Therefore, the patient meets this criterion.\n\nAssessment of eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.\n\nTrial-level eligibility: 1) Would consider referring this patient to this clinical trial upon further investigation.<|eot_id|>",
        "label": 0
    }
}